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ABSTRACT cDNA clones encoding proteolipid protein
(PLP) were isolated from a mouse brain library and sequenced.
We describe two transcripts arising from the PLP locus by
alternative splicing: the major one encodes the 277-amino acid
PLP protein and the minor one corresponds to the DM-20
protein, a PLP-like protein of20,000Mr that shares both amino
and carboxyl regions with PLP. These two transcripts lack -70
bases in PLP mRNA from the dysmyelinating jimpy mutant.
The deletion spans amino acids 208-232; however, this region
is present in thejimpy PLP-encoding gene. We propose that the
jimpy mutant suffers a point mutation or the deletion of a few
bases in the PLP gene that alters the normal splicing pattern
and generates partially deleted PLP transcripts.
The most abundant protein of the myelin sheath is proteolipid
protein (PLP), which is elaborated by oligodendrocytes in the
central nervous system. PLP plays a structural role in myelin
and probably promotes the apposition of extracellular sur-
faces of the myelin lamellae. PLP appears to be encoded by
a single gene because (i) a simple pattern ofbands is observed
on Southern blots probed with rat (1) or bovine (2) PLP
cDNA, (ii) in situ hybridization occurs at a single chromo-
somal location (3), and (iii) analysis of overlapping human
PLP genomic clones supports this conclusion (L.D.H. and
J.A.B., unpublished data). Another proteolipid closely relat-
ed to PLP is also found in reduced amounts in the myelin
sheaths of oligodendrocytes. This proteolipid (DM-20) has
identical amino acid sequences as PLP at the amino and
carboxyl termini, but DM-20 is missing an internal domain of
=40 amino acids (4-6).
Our laboratory has isolated genomic and cDNA clones for
both human and mouse PLP, and we report here the sequence
of the highly conserved mouse PLP cDNA. RNA probes
were synthesized from mouse cDNA to characterize RNA
processing from the PLP locus and identify putative muta-
tions ofthe PLP-encoding gene, employing methods based on
the ability of ribonuclease A to recognize and cleave single
base mismatches in RNA heteroduplexes (7, 8). Two mouse
dysmyelinating disorders, jimpy (jp) (9) and that associated
with thejp allele (10) jimpymsd, were of particular interest as
candidates for PLP mutations because of the absence ofPLP
protein in jimpy mice (11), the identification of the oligoden-
drocyte as the affected cell (for review, see ref. 12), and the
mapping of the PLP (this work; refs. 3 and 13) and jimpy (9,
10) locus to the X chromosome. We report that both PLP and
DM-20 transcripts are partially deleted in jimpy mice, which
accounts for the dysmyelinating phenotype of these mutant
mice. Moreover, the existence of a single mutation that
affects PLP and DM-20 transcripts suggests that one gene
encodes both PLP and DM-20 by alternative splicing.
MATERIALS AND METHODS
Chromosome Mapping. DNA from Chinese hamster-
mouse hybrid cells (14) was blotted onto nylon membranes
and probed with a 2-kilobase (kb) EcoRI fragment (subcloned
from phage X PLP1) containing both coding and noncoding
regions of mouse PLP cDNA. The hamster form ofPLP was
evident as a 10-kb HindIII band, readily distinguishable from
the 5-kb major murine band.
RNA Isolation and Mapping. Wild-type mice were (C57BL/
6J x C3H/HeJ)Fl, and all mutant mice were maintained on
this background. RNA was extracted from mouse brain with
guanidinium thiocyanate, selected with oligo(dT)-cellulose
and either subjected to electrophoresis on formaldehyde gels
(1 ,ug per lane) and transferred to nylon membranes or
directly dotted onto nylon membranes (20 ng to 10 ,ug per
spot). Filters were probed with either nick-translated mouse
PLP cDNA or mouse myelin basic protein (MBP) cDNA that
was a 600-base-pair (bp) Pst insert from plasmid pdF191 (15)
or 32P-phosphorylated 25-mer nucleotides. Several RNA and
dot blots were scanned on a Shimadzu densitometer, and the
results were averaged.
To prepare RNA probes, the 980-bp EcoRI-Sac I fragment
from phage X PLP 2 was subcloned into plasmid pGEM3 and
digested with either Nco I, Bgl II or EcoRI. Single-stranded,
antisense RNA probes were synthesized from the three
templates using the SP6 RNA polymerase as recommended
by Promega Biotec (Madison, WI) with 50 ,uCi of [a-32P]CTP
(400 Ci/mmol; 1 Ci = 37 GBq; Amersham) and purified on
denaturing gels. RNA probes (2 x 105 cpm) were hybridized
overnight at 45°C with 0.1-1 ,ug of poly(A)+ RNA in 80%
formamide/40 mM Pipes, pH 6.7/0.4 M NaCl/1 mM EDTA
as described by Melton et al. (7). Single-stranded regions
were eliminated with either RNase A (12 ,ug at 16°C for 1 hr;
Boehringer Mannheim) or RNase T1 (166 units at 16°C for 1
hr; Bethesda Research Laboratories) or a combination, and
the protected fragments were resolved on 8 M urea/5%
acrylamide gels.
RESULTS AND DISCUSSION
Conservation of PLP Sequence. PLP is remarkably well
conserved among mouse (this report), rat (1, 16), cow (2), and
human (C.P., L.D.H., and R.A.L., unpublished work) at the
amino acid and nucleotide level. The protein encoded by the
mouse PLP cDNA (Fig. 1) is identical to the rat (16) and
human (C.P., L.D.H., and R.A.L., unpublished work) PLP
and displays only two conservative amino acid differences
from the bovine sequence (2). The striking degree of conser-
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GAGGACAAAGATACTCAGAGAGAAAAAGTAAAGGACAGAAGAAGGAGACTGGAGAGACCAGGATCCTTCCAGCTGAGCAAAGTCAGCCGCAAAACAGACTAGCCAACAGG 110
CTACAATTGGAGTCAGAGTGCCAAAGACATGGGCTTGTTAGAGTGTTGTGCTAGATGTCTGGTAGGGGCCCCCTTTGCTTCCCTGGTGGCCACTGGATTGTGTTTCTTT 219
MetGlyLeuLeuGluCysCysAlaArgCysLeuValGlyAlaProPheAlaSerLeuValAlaThrGlyLeuCysPhePhe 27
GGAGTGGCACTGTTCTGTGGATGTGGACATGAAGCTCTCACTGGTACAGAAAAGCTAATTGAGACCTATTTCTCCAAAAACTACCAGGACTATGAGTATCTCATTAAT 327
GlyValAlaLeuPheCysGlyCysGlyHisGluAlaLeuThrGlyThrGluLysLeuIleGluThrTyrPheSerLysAsnTyrGlnAspTyrGluTyrLeuIleAsn 63
GTGATTCATGCTTTCCAGTATGTCATCTATGGAACTGCCTCTTTCTTCTTCCTTTATGGGGCCCTCCTGCTGGCTGAGGGCTTCTACACCACCGGCGCTGTCAGGCAG 435
ValIleHisAlaPheGlnTyrValIleTyrGlyThrAlaSerPhePhePheLeuTyrGlyAlaLeuLeuLeuAlaGluGlyPheTyrThrThrGlyAlaValArgGln 99
ATCTTTGGCGACTACAAGACCACCATCTGCGGCAAGGGCCTGAGCGCAACGGTAACAGGGGGCCAGAAGGGGAGGGGTTCCAGAGGCCAACATCAAGCTCATTCTTTG 543
IlePheGlyAspTyrLysThrThrIleCysGlyLysGlyLeuSerAlaThrValThrGlyGlyGlnlLysGlyArgGlySerArgGlyGlnHisGlnAlaHisSerLeu 135
GAGCGGGTGTGTCATTGTTTGGGAAAATGGCTAGGACATCCCGACAAGTTTGTGGGCATCACCTATGCCCTGACTGTTGTATGGCTCCTGGTGTTTGCCTGCTCGGCT 651
GluArgValCysHisCysLeuGlyLysTrpLeuGlyHisProAspLysPheValGlyIleThrTyrAlaLeuThrValValTrpLeuLeuValPheAlaCysSerAla 171
GTACCTGTGTACATTTACTTCAATACCTGGACCACCTGTCAGTCTATTGCCTTCCCTAGCAAGACCTCTGCCAGTATAGGCAGTCTCTGCGCTGATGCCAGAATGTAT 759
ValProValTyrIleTyrPheAsnThrTrpThrThrCysGlnSerIleAlaPheProSerLysThrSerAlaSerIleGlySerLeuCysAlaAspAlaArgMetTyr 207
GGTGTTCTCCCATGGAATGCTTTCCCTGGCAAGGTTTGTGGCTCCAACCTTCTGTCCATCTGCAAAACAGCTGAGTTCCAAATGACCTTCCACCTGTTTATTGCTGCG 867
GlyValLeuProTrpAsnAlaPheProGlyLysValCysGlySerAsnLeuLeuSerIleCysLysThrAlaGluPheGlnMetThrPheHisLeuPheIleAlaAla 243
TTTGTGGGTGCTGCGGCCACACTAGTTTCCCTGCTCACCTTCATGATTGCTGCCACTTACAACTTCGCCGTCCTTAAACTCATGGGCCGAGGCACCAAGTTCTGAGCTC 976
PheValGlyAlaAlaAlaThrLeuValSerLeuLeuThrPheMetIleAlaAlaThrTyrAsnPheAlaValLeuLysLeuMetGlyArgGlyThrLysPhe*** 277
CCATAGAAACTCCCCTTTGTCTAATAGCAAGGCTCTAACCACACAGCCTACAGTGTTGTGTTTTAACTCTGCCTTTGCCACTGATTGGCCCTCTTCTTACTTGATGAGTA 1086
TAACAAGAAAGGAGAGTCTTGCAGTGATTAATCTCTCTCTGTGGACTCTCCCTCTTAGTACCTCTTTTAGTCATTTTGCTCCACAGCAGGCTCCTGCTAGAAATGGGGGA 1196
TGCCTGAGAAGGTGACTCCCCAGCTGCAAGTCGCAGAGGAGTGAAAGCTCTAATTGATTTTGCAAGCATCTCCTGAAGACCAGGATGTGCTTCCTTCTCAAAGGGCACTT 1306
CCAACTGAGGAGAGCAGAACGGAAAGGTTCTCAGGTAGAGAGCAGAAATGTCCCTGGTCTTCTTGCCATCAGTAGGAGTCAAATACATTCTCTTTGATGCACAAAACCAA 1416
GAACTCACTCTTACCTTCCTGTTTCCACTGAAGACAGAAGAAAATAAAAAGAATGCTAGCAGAGCAATATAGCATTTGCCCAAATCTGCCTCCTGCAGCTGGGAGAAGGG 1526
TGTCAAAGCAAGGATCTTTCGCCCTTAGAAAGAGAGCTCTGACGCCAGTGGCAATGGACTATTTAAGCCCTAACTCAGCCAACCTTCTTACGGCAATTAGGGAGCACAGT 1636
GCCTGTATAGACAAAGCGGGGCGGAGGGGGGGGGCATCATCTGTCCTTATAG'CTCATTAGGAAGAGAAACAGTGTTGTCAGGATCATCTCACTCCCTTCTCCTTGATAAC 1746
AGCTACCATGACAACCTTGTGGTTTCCAAGGAGCTGAGAATAGAAAGGAACTAGCTTATTTGAAATAAGACTGTGACCTAAGGAGCATCAGTTGGTGGATGCTAAAGGTG 1856
TAATTTGAAATGGCCTTCGGGTAAATGCAAGATACTTAACTCTTTGGATAGCATGTGTTCTTCCCCCACCCCTATCCGCTAGTTCTGGCCCCTGGCCTCTGGCATAATAT 1966
CTTCACAATGGTGCTTTTTTTCCTGGGGTTTTATCCATTCACTCATAGCAGGTGATTAGACGATCTTGATTAGTTTCATATTTCCCAATTGTTTATCTCTTGTTTGGAGT 2076
TGTATCAGAAAGACCTGGAGGATGATTCTTTGAGCATAGTTCTTTTTGAAAACAAGAAAGAGAAACTGGGCAGAAAGCATCACAAAAATATTTGAAATTGTACGGTCCCA 2186
TGAAATTATTGGGAATTCCCCCAAGTAGTCTACCATTTGTAGAACTAGGCTTGATAAATTTGAACCTCAATTTGAATAATTGGTCTGGTATTTTCTTTTCTAATAAATGA 2296
CAGATGATTTTACTTGCTAATATTATCTCAGCATTTTGATAATTTAGGCTTACCATAGAAGTTACTGTCTCTTGGTATATATAGGTCACATAATAGATTCTGCCAGCTGT 2406
TAGCTGTTCAGTTCATAAGCTTCTCATAGAGCTCTGGAGCCGCAGAGAGGACNGGCAGAATTTGAAACCTAAAGAACTCCCAGATTTTCAGGCTTATCCTGTATTTGTTA 2516
ACAAAGGGTGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAAAGAAAAGGAAGGAAGGAAGGAAGGAAGA 2626
AAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAGAAAAAAAAAGCCCCTGATCGAATTTCCTGAGGAAAAGTTATTGTAGCTGTTTCATTG 2736
TAGATTTGTGCTGTCATTCCCCAAAGTGCTTTCTGCTGTGTTGAAAGAGATATAAGAATTTACAAGAAGACACTTGAGACTTGTTCTTGGGCCAATATATAAGGTAAACA 2846
AGCAGGATGCACAAGAGTGAGGAGAGCTAAGGAATTC 2883
FIG. 1. Sequence of the murine PLP cDNA. Two overlapping CDNA clones were selected from a mouse brain library (1S) with
oligonucleotide probes (I and II of Fig. 3) complementary to rat PLP. Inserts subcloned from phage A PLP1 (position 199-2883) were completely
sequenced by chemical (18) or dideoxy chain termination (19) methods. The most 5' 300 bases of phage A PLP2, which extends from position
one to the secondary polyadenylylation site at 2288, were also sequenced. The nearly full-length cDNA sequence lacks 24 bases of 5' untranslated
sequence (from results of primer extension experiments) and the last hundred bases of 3' untranslated sequence, including the major
polyadenylylation site. The purine repeat region is underlined.
vation among PLP genes is not unexpected for a structural
protein whose critical function tolerates little diversity and is
similar to that observed for the other major structural protein
in myelin, MBP (20). A distinguishing feature of the 3'
untranslated region of the mouse PLP cDNA is the 172-base
purine sequence (underlined in Fig. 1) composed chiefly of
the sequence GAAA repeated 33 times. This region is
reminiscent of satellite DNA, which contains short purine-
rich repeats (21), and it has been also observed by M. Wilson
and colleagues in PLP cDNA clones from a number of
different mouse strains (M. Wilson, personal communica-
tion). A remnant of this region is present in rat PLP (1) at the
corresponding site. The rat sequence has a 33-base stretch in
which the GAAA motif is repeated only six times and
possibly represents a partial deletion of an ancestral, highly
duplicated, purine-rich region.
Another distinction among PLP genes is the use of alter-
native polyadenylylation sites. Mouse PLP has two function-
al polyadenylylation sites: the major one that produces the
3200-base transcript and a minor site (underlined in Fig. 1)
that yields a 2400-base transcript (Fig. 2, lane 3). The
2400-base transcript was characterized by its hybridization to
coding region probes and inability to hybridize to the terminal
700 bases ofPLP cDNA (Fig. 2); moreover, the X PLP 2 clone
(Fig. 1) appears to be a full-length copy of the 2400-base
mRNA. Despite the conservation of polyadenylylation sites
in the 3' untranslated region of mouse, rat (1), and, to a lesser
extent, human (C.P., L.D.H., and R.A.L., unpublished
work) PLP mRNAs, each species uses different secondary
polyadenylylation sites in addition to the major site at =3000
bases. The rat uses a secondary polyadenylylation site
corresponding to position-1480 of Fig. 1 (N. Zeller, unpub-
lished results; ref. 1) that is present but not utilized signifi-
cantly in mice. The rat mRNA also shares the polyadenylyla-
tion site at -2290 (Fig. 1) with mouse, but rat mRNA displays
only trace amounts of the 2400-base transcript (1). Both the
rat (N. Zeller, unpublished results) and the mouse (Fig. 2,
lane 3) also have small amounts of a 4800-base PLP mRNA
whose termini are unknown. Unlike rodents, human PLP
mRNA has a single transcript of -3000 bases (Fig. 2, lane 4;
C.P., L.D.H., and R.A.L., unpublished work). Secondary
polyadenylylation sites are used in <1% of human PLP
transcripts, suggesting that the species variation in the choice
of polyadenylylation sites does not critically affect PLP
production.
PLP Maps to the X Chromosome. As a first step in
determining whether the X-linkedjp mutation (9, 10) carried
by jimpy mice maps to the PLP-encoding gene, we tested a
panel of hamster-mouse hybrids for the presence of PLP.
Table 1 shows that PLP also resides on the murine X
chromosome. No discordancy was present for the X chro-
mosome/PLP association, and PLP was not associated with
any other chromosomes. This result has been extended by
Dautigny et al. (3), who report that the PLP gene in mouse is
located at XF1, the vicinity of the jp mutation.
PLP mRNA Is Partially Deleted in Jimpy Mice. Jimpy mice
have reduced levels of PLP mRNA, approximately 10% of
control mice, at the peak period of myelination (18 days
postnatal) as shown in Fig. 2. However, this effect is not
specific for PLP mRNA: jimpy mice show commensurately
reduced mRNA levels for the other major myelin protein,
MBP. Jimpy mutant is unusual among the dysmyelinating
disorders in its drastic effects on both PLP and MBP mRNA.
Shiverer mutant mice have a genome partially deleted for the
MBP-encoding gene (15, 22, 23) and, consequently, synthe-
size only small amounts of abnormal myelin, but PLP mRNA
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FIG. 2. PLP message in normal and dysmyelinating mouse brain. (A) PLP transcripts detected in poly(A)4 mRNA, 1 ,ug per lane, with a
2-kb EcoRI probe subcloned from phage X PLP 1: lane 1, 18-day jimpy brain; lane 2, 6-8-day wild-type brain; lane 3, 18-day wild-type brain;
and lane 4, adult human (Alzheimer) brain. When this blot was reprobed with the most 3' end of PLP cDNA (679-bp EcoRI fragment subcloned
from phage X PLP 1), the 2400-base transcript did not hybridize. 14C-labeled rRNA (not shown) was used to mark size (in bases). (B) The total
amount of PLP or MBP mRNA for each sample is expressed relative to the amount present at the peak of PLP or MBP synthesis in 18-day-old
wild-type (+/+) mouse brain. Dysmyelinating mice included jimpy (jp/Y), shiverer (shi/shiO, and quaking (qk/qk). ND, not determined.
levels are unaffected. Similarly, quaking mutant mice have a
reduced capacity to myelinate (12), but PLP and MBPmRNA
levels are unaffected.
Jimpy mice produce all three PLP mRNA transcripts seen
in wild-type mice (in overexposed autoradiograms of Fig.
2)-the 4800-, 3200-, and 2400-base transcripts. To determine
whether the PLP message is altered in these mice as well as
being quantitatively affected, we analyzed the message with
a series of overlapping RNA probes complementary to the
coding region of PLP. The results of these experiments,
shown in Fig. 3, identify and map a deletion in the jimpy PLP
mRNA and provide evidence for alternative splicing from the
wild-type PLP locus. When poly(A)+ mRNA was hybridized
with 32P-labeled RNA probes, then RNase-digested, and
electrophoresed on denaturing gels, two classes of protected
fragments were observed. In wild-type mice, transcripts
corresponding to the full-length probe were evident-207
Table 1. PLP maps to the X chromosome
Hybrid clones, no.
Mouse PLP presence/chromosome Percent
chromosomes retention discordant
+1+ -I- +1- -1+
1 9 2 3 3 35
2 7 3 4 2 38
3 6 3 1 1 18
4 5 3 6 2 50
5 2 5 10 0 59
6 7 3 5 2 41
7 9 2 2 3 31
8 4 4 7 1 50
9 4 5 7 0 44
10 3 5 8 0 50
11 0 4 9 0 69
12 4 1 3 3 55
13 4 3 3 1 36
14 4 5 7 0 44
15 7 0 0 4 36
16 4 3 3 1 36
17 8 3 1 1 15
18 3 4 4 0 36
19 8 5 3 0 19
X 10 5 0 0 0
bases for the Sac I-Nco I probe I, 519 bases for the Sac I-Bgl
II probe II, and 917 bases for the Sac I-EfoRI probe III. A
second class of minor bands was also seen in wild-type mice.
The sizes and position ofthese bands suggest they are derived
from a mRNA for the DM-20 protein, a PLP-like protein
missing an internal domain of PLP (4-6). The domain absent
in DM-20 has been characterized by Trifilieff et al. (6) using
an antibody directed against a peptide from amino acid 117 to
129 of the PLP sequence. Their results, along with our
preliminary data, mapping the intron-exon junctions of the
human PLP gene (L.H., unpublished results) position the
region corresponding to the DM-20 deletion as shown in Fig.
3C. A full-length probe to the mouse PLP-coding region
protects two minor transcripts of 481 and 382 bases, whereas
the probe that contains the 3' half of mouse PLP-coding
region only protects the 382-base band. These results place
the missing region ofthe minor transcript in the same position
(Fig. 3) as that predicted by antibody and mapping data and
suggest that DM-20 may represent an alternatively spliced
form of PLP. The relatively small amounts of the putative
DM-20 transcripts are consistent with this hypothesis, be-
cause DM-20 protein is present at only 10% of the levels of
PLP protein in rat brain (24).
Jimpy mRNA displayed a dramatically different pattern of
protected fragments. All RNA probes generated a small
144-base transcript not detected in wild-type mice (Fig. 3A).
RNA probes II (Sac I-Bgl II 540) and III (Sac I-EcoRI 980)
also generated bands of 325 and 744 bases, respectively.
Comparison of the summed sizes ofjimpy fragments for each
RNA probe with the full-length transcripts found in wild-type
mice indicates that jimpy PLP mRNA is deleted for -70
bases at the Nco I site (Fig. 3C). The existence of a deletion
at this site in jimpy PLP mRNA was confirmed by another
approach. An oligonucleotide corresponding to the presump-
tive deleted region injimpy PLP mRNA was synthesized and
tested for hybridization tojimpy mRNA. As apparent in Fig.
3B and summarized in 3C, of the five oligonucleotide probes
used, only the probe corresponding to the deleted region
(probe 7) failed to hybridize to jimpy mRNA. Altered PLP
transcripts in jimpy mice were also identified in an S1
nuclease experiment with a rat PLP probe (3), which differed
from the mouse sequence (Fig. 1) at 19 bases; due to the
ability of S1 nuclease to detect a single base mismatch,
interpretation of these results is not straightforward.
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FIG. 3. The coding region ofPLP mRNA is partially deleted injimpy mutant mice. (A) PLP transcripts detected with RNA probes I (205-base
Sac I-Nco I), 11 (540-base Sac I-Bgl II), and III (980-base Sac I-EcoRI) in (C57BL/6J x C3H/HeJ)F1 mouse brain (+), jimpy Qp) orjimpymsd
Upms). No differences were observed between several wild-type mouse strains [(C57BL/6J x C3H/HeJ)Fl, DBA, and NIH]. All samples were
treated with RNase A before electrophoresis except for the three samples marked I1T1, which were incubated with RNase T1. RNase T1 and
RNase A yielded similar patterns, although RNase T1, which cleaves only after guanine residues, was not always as complete (compare II and
I1T1). Each lane corresponds to 20 ng of wild-type poly(A)+ mRNA or 200 ng of mutant poly(A)+ mRNA. The 2400- and 3200-base PLP mRNAs
shown in Fig. 2 should generate identical patterns of protected fragments, as the two mRNAs differ only in the length of their 3' untranslated
region. Phage 4X174 treated with Hae III was used as a size marker: RNA transcripts of known sequence (RNA probes I, II, and III) appear
1-5% smaller than single-stranded DNA on these gels. (B) Deletion in PLP mRNA ofjimpy detected by oligonucleotide probes (see Fig. 3C
for positions of probes 1, 2, 3, 5, and 7) on dot blots containing 1 Itg of poly(A)+ RNA from wild-type (+) mouse brain or 10 jig of poly(A)+
RNA from jimpy (jp) or jimpymsd (jp"'l) mouse brain. (C) The schematic shows PLP mRNA with the coding region boxed, and the regions
corresponding to sequences deleted from DM-20 (ADM-20) orjimpy (D6jp) mRNA marked with open boxes. Restriction sites used to generate
RNA probes are indicated above the PLP mRNA. The positions ofRNA probes I-III are indicated with a heavy line; the precise size of each
probe in bases is shown above the line. Beneath each RNA probe are the mRNA fragments that protected the probe from RNase digestion (wavy
lines) in wild-type (+/+) orjimpy (jp/Y) mouse brain. The size of each transcript as estimated from the DNA standard is indicated above the
transcript. The summary of the jp"-d-protected fragments is not included, because the pattern observed for jp1id was identical to that found
for wild type (A). The transcripts corresponding to a DM-20 mRNA (382 and 481 bases) are shown as thin wavy lines. The oligonucleotide probes
used in B are shown directly below the PLP mRNA in bracketed lines with the results of hybridization tojimpy mRNA summarized below the
brackets: + indicates hybridization of the 25-mer to jimpy poly(A)+ mRNA, - indicates absence of hybridization.
Jimpy mRNA also contained minor DM-20 transcripts but
contained only the 481-base-protected fragment correspond-
ing to the 5' end ofthe coding region. The other halfofDM-20
mRNA (382-base-protected fragment) was not apparent,
indicating that DM-20 transcripts in jimpy mutants, like the
PLP transcripts, are also deleted for the 70 bases around the
Nco I site. These results provide further support for the
existence of a single gene that encodes both PLP and DM-20
by alternative splicing. The other possibility, the existence of
one gene for PLP and a closely linked one for DM-20, is
unlikely becausejimpy mice would have to have mutations at
both gene loci to produce the observed pattern (Fig. 3).
The structure of the PLP gene in jimpy mice was further
characterized in a series of genomic Southern blots with a
battery of enzymes that flanked or encompassed the mRNA
deletion (Bsm I, BstNI, Nco I, Nla IV, Pvu II, and Scr FI) or
0 PI jpmR'.%A %.I
-.1
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enzymes that might cut within adjacent introns (Sau 3a, Alu
I, Rsa I, BamHI, HindIII, EcoRP, Pst I, Bgl II, Pvu II, Xba
I, Xho I, EcoRV, Dra I, Hpa I, Kpn I, Nde I, Nru I, Sma I
or Sph I). Surprisingly, no differences between jimpy and
wild-type DNA were evident for any restriction enzymes
used (data not shown). Therefore, the jimpy PLP-encoding
gene may have either a point mutation or a very small deletion
thaat destroys a normal splice site. Both the 5' and 3' borders
of the deleted jimpy mRNA coincide with the boundaries of
the fifth exon sequenced from human PLP genomic clones
(L.D.H. and J.A.B., unpublished results), which further
supports the hypothesis that there is a mutation in the donor
or acceptor splice site of the jimpy PLP gene. Inappropriate
splicing would delete exactly 74 bases of coding region from
the PLP transcript to produce the shortened jimpy messages
observed in Fig. 3, whereas the gene itself would appear
intact by Southern analysis.
PLPmRNA Is Not Detectably Altered in Jiupy"md Mice. The
allelic form ofjp jpmd, produced similarly reduced levels of
PLP mRNA in brain but displayed a wild-type profile with
RNA or oligonucleotide probes (Fig. 3 A and B). The
jimpymsd phenotype could, nonetheless, result from an un-
detected point mutation in the PLP coding region. Of the
eight possible single base pair mismatches, Perucho and
coworkers found that T-U and U*U mismatches were not
readily cleaved by RNase A, indicating that only three-
fourths of the single base mutations would be detected by
these methods (8). An alternative possibility for the Is
mutation is that it is a regulatory mutation at the PLP locus
that sharply reduces PLP mRNA synthesis. Either mutation,
the identification of which awaits the characterization of
jimpymsd genomic clones, would be consistent with thejimpymsd phenotype in which the abnormalities present are
similar to jimpy but much less severe (25).
PLP Is Required for Oligodendrocyte Maturation. Our
results demonstrate that a mutation affecting splicing at the
PLP locus results in the jimpy phenotype. It is not known
whether translation of the altered PLP transcripts occurs in
jimpy mutant mice. PLP mRNA from jimpy could encode a
protein that would preserve the first 207 amino acids of the
PLP sequence. The 74-base deletion, whose end points
correspond to the boundaries of the fifth exon for PLP in the
human genome (L.D.H., unpublished data), would destroy
the proper reading frame and create a shortened protein (243
amino acids) with pt unique carboxyl terminus. No' evidence
of PLP in jimpy mice has been reported by immunologic
techniques (11), although the mutant protein may have an
altered conformation that circumvents immunologic detec-
tion, or the abnormal protein may be rapidly degraded.
Like the other dysmyelinating mutants, jimpy and its
human counterpart, Pelizaeus-Merzbacher disease (26), fail
to synthesize myelin. Yet the absence of PLP creates more
devastating effects than those effects observed by halting
myelination in the other dysmyelinating disorders. A curious
aspect of the lack of PLP is the block in oligodendrocyte
maturation evident in jimpy mutant mice: mature oligoden-
drocytes are absent from both jimpy (27, 28) and Pelizaeus-
Merzbacher (26) brains, observations consistent with the
markedly reduced levels of oligodendrocyte-specific mRNA
(Fig. 2), proteins, and lipids in affected brains (for review, see
ref. 12). Conceivably, a mutant PLP protein is produced injimpy mice that is toxic to the oligodendrocyte at the initial
stages of myelination. More likely is the possibility that the
absence of PLP precludes further differentiation of jimpy
oligodendrocytes. In addition to its structural role in the
myelin sheath, PLP may function at a critical stage of
oligodendrocyte development that precedes myelin assem-
bly. It is of note that PLP acts as an ionophore in vitro (29,
30), a property that may contribute to the essential role of
PLP in oligodendrocyte maturation.
Note. While this report was being reviewed, R. Milner and colleagues
submitted their sequence ofjimpy cDNA, which was deleted for 74
bases as characterized in this work (17).
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